基托桑纳米颗粒的临床视角,用于传染病管理
Fahima Dilnawaz1, Sarbari Acharya2, Anwesha Kanungo2
1Department of Biotechnology, School of Engineering and Technology, Centurion University of Technology and Management, Jatni, Bhubaneswar, Odisha 752050 India.
Polymer bulletin (Berlin, Germany)
|June 26, 2023
概括
素纳米颗粒 (CNPs) 提供了一种有前途的新方法来管理传染病. 这些生物相容纳米颗粒显示出作为抗菌剂和药物输送载体的潜力,解决新兴病原体带来的挑战.
科学领域:
- 纳米医学是一种纳米医学.
- 传染病研究 传染病研究
- 聚合物科学 聚合物科学
背景情况:
- 传染病仍然是一个重大的全球健康威胁,现有的治疗方法有时证明对抗新型病原体不足,如SARS-CoV-2,埃博拉和寨卡病毒.
- 传统的抗微生物和抗病毒药物面临局限性,需要探索先进的治疗策略.
- 纳米配方由于其独特的特性和传递能力,正在成为对抗传染病的强大新范式.
研究的目的:
- 为传染病管理提供基多纳米颗粒 (CNPs) 的综合审查.
- 突出CNP作为对一系列传染病原体的替代治疗策略的潜力.
- 讨论CNP在打击微生物威胁中的当前和潜在的临床应用.
主要方法:
- 审查现有的关于奇托桑纳米颗粒及其在传染病中的应用文献.
- 对酸盐的特性进行分析,包括生物相容性,生物降解性和适应性.
- 检查CNP作为抗菌剂,药物/疫苗输送系统和伤口带的作用.
主要成果:
- 素纳米颗粒 (CNPs) 由于其生物相容性,生物降解性和适应性,显示出显著的潜力.
- 作为抗菌剂,药物和疫苗输送工具,以及用于传染病治疗的伤口包裹应用中,CNP是有效的.
- 虽然目前感染性疾病中CNP的临床试验数据有限,但预计其应用将增长,特别是考虑到新出现的病原体.
结论:
- 基托桑纳米颗粒代表了预防和管理传染病的多功能和有前途的平台.
- CNP的独特特性使其成为应对各种微生物挑战的潜在灵丹妙药.
- 进一步的临床研究和CNP的应用是有必要的,以充分实现它们对传染病的治疗潜力.
相关概念视频
01:28Fungal Phylum Microsporidia
43
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
43
01:29Microorganisms in Medicine and Therapeutics
68
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
68